Research on GlaxoSmithKline plc and Merck & Co. Inc. -- Big Pharma Stable for Now
(firmenpresse) - JOHANNESBURG, SOUTH AFRICA -- (Marketwire) -- 10/24/11 -- offers investors comprehensive research on the Drug Manufacturers - Major industry and has completed analytical research on (NYSE: GSK) and (NYSE: MRK). Register with us today at to have free access to these researches.
Large-cap pharmaceutical companies have performed steadily in recent months despite market volatility. Both GlaxoSmithKline plc and Merck and Co. Inc. have held their value well since the markets began to really shift at the beginning of August. While this is certainly encouraging, these major pharmaceutical companies will likely need to maintain their drug pipelines to continue on this course. Investors looking for free research on are welcome to sign up at .
is an online platform where investors doing their due-diligence on the Drug Manufacturers - Major industry can have easy and free access to our analyst research and opinions on GlaxoSmithKline plc and Merck & Co. Inc.; all investors need to do is register for a complimentary membership at .
Expiring exclusivity rights on several major drugs are a significant concern to several companies at this time. As a result, acquisition and buyout rumors have begun surfacing at increased rates. Investors in the industry would be wise to track all of the latest merger and acquisition activities. Register now at to have free access to our reports on the Drug Manufacturers - Major industry.
Avoiding production delays will also be pivotal. The Food and Drug Administration recently issued a warning letter to GlaxoSmithKline alleging manufacturing violations at its UK-based plant. The letter warned that until all corrections have been completed, the FDA may withhold approval of new applications. Investors looking for free research on are welcome to sign up at .
Visit to see how companies in this industry have grown over the past years and how they are expected to perform in the future.
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 24.10.2011 - 06:00 Uhr
Sprache: Deutsch
News-ID 1048859
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
JOHANNESBURG, SOUTH AFRICA
Phone:
Kategorie:
Commercial & Investment Banking
Anmerkungen:
Diese Pressemitteilung wurde bisher 38 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Research on GlaxoSmithKline plc and Merck & Co. Inc. -- Big Pharma Stable for Now
"
steht unter der journalistisch-redaktionellen Verantwortung von
StockCall (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
